A Pill to Reverse Alzheimer’s?

Dr. Frank Longo at Stanford U. School of Medicine is now conducting phase II human trials on a drug called LM11A-31, or C31. Already successful in mice and proven safe in humans, the drug interrupts the signals that cause neurons to deteriorate. Not only is C31 valuable for preventing Alzheimer’s and other dementias, but mice studies show it may possibly reverse damage that has already occurred–something once thought impossible.